Management of Women With Superficial Dyspareunia

Superficial Dyspareunia Clinical Trial

— dyspareunie  

Official title:

Management of Women With Superficial Dyspareunia

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06142851
• Other study ID #: 2023_RIPH_017_PEC-dyspareunie
• Status: Not yet recruiting
• Start date: December 1, 2023
• Est. completion date: May 1, 2024

Study information

• Verified date: November 2023
• Source: Université de Reims Champagne-Ardenne
• Contact: Barbe Coralie, DR
• Phone: 0326913665
• Email: coralie.barbe[@]univ-reims.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Superficial dyspareunia are persistent or recurrent pains during an attempt at sexual intercourse or during effective penetration.

They affect between 3 to 18% of women and are a source of physical and psychological suffering.

Some health professionals (gynecologists, general practitioners, midwives) are confronted daily with these complaints.

The approach of sexuality remains a complex subject even within the medical field. As a result, communication between women and health professionals can be difficult, leading to delayed diagnosis or inadequate management.

Description:

The main objective is to describe the management of superficial dyspareunia by health professionals.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 2000
• Est. completion date: May 1, 2024
• Est. primary completion date: February 1, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Aged 18 or over

• Superficial dyspareunia, i.e.:

• Having already had several painful vaginal penetrative sex

• Having pain at the intromission (at the beginning of the vagina and at the level of the vulva) and/or at the beginning of penetration (by a penis, fingers, sextoys)

• Having persistent and/or recurrent pain (appearing in a manner regular)

• Agreeing to participate in the study

Exclusion Criteria:

• Minors

• Protected by law (guardianship, curatorship, safeguarding of justice)

• Refusing to participate in the study

Related Conditions & MeSH terms

• Dyspareunia
• Superficial Dyspareunia

Intervention

Other:
• Data collection
data collection

Locations

Country	Name	City	State
France	Ufr Medecine Urca	Reims
France	Université de Reims Champagne Ardenne	Reims

Sponsors (1)

Lead Sponsor	Collaborator
Université de Reims Champagne-Ardenne

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	medical history	Question to the woman about possible pain during sexual intercourses by an health professional (yes or no)	Day 0